Filtered By:
Condition: Diabetes
Countries: USA Health
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 465 results found since Jan 2013.
Nanocarriers and Diabetes: New Vistas and the way ahead
Curr Pharm Biotechnol. 2022 Dec 27. doi: 10.2174/1389201024666221227140728. Online ahead of print.ABSTRACTWorld Health Organization has reported an estimated 1.5 million deaths directly due to diabetes in 2019. Center for Disease Control and Prevention, in its National Diabetes Statistics Report, 2020, says that 1 in 10 United States residents has diabetes. This rapid progression of diabetes is noteworthy despite significant advances in the field of antidiabetic medicine. The critical challenges in treatment are dyslipidemia, hyperinsulinemia, and hyperglycemia. The latest research has also linked diabetes to carcinogenesi...
Source: Current Pharmaceutical Biotechnology - December 29, 2022 Category: Biotechnology Authors: Pankaj V Dixit Dinesh K Mishra Sanjay Sharma Rupesh K Gautam Source Type: research
Hyperbaric oxygen therapy research: an analysis of the 100 most-cited publications from 2011 to 2020
CONCLUSIONS: The annual number of HBO2 publications was stationary. The citation numbers showed a skewed distribution. The United States was the leading country in HBO2 research. Of 26 application fields, traumatic brain injury, stroke, and diabetic foot were the leading three fields.PMID:36446297 | DOI:10.22462/07.08.2022.11
Source: Undersea and Hyperbaric Medicine - November 29, 2022 Category: Sports Medicine Authors: Hsin-Tzu Yeh Ching-Hsing Lee Source Type: research
